bioAffinity Technologies, Inc.
General ticker "BIAFW" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $4.6M (TTM average)
bioAffinity Technologies, Inc. follows the US Stock Market performance with the rate: 28.9%.
Estimated limits based on current volatility of 14.5%: low 0.20$, high 0.27$
Factors to consider:
- Total employees count: 9 as of 2022
Short-term BIAFW quotes
Long-term BIAFW plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $2.53MM | $9.36MM | $6.16MM |
| Operating Expenses | $10.51MM | $18.32MM | $16.73MM |
| Operating Income | $-7.97MM | $-8.95MM | $-10.57MM |
| Non-Operating Income | $0.06MM | $-0.07MM | $-4.29MM |
| Interest Expense | $0.04MM | $0.09MM | $0.04MM |
| R&D Expense | $1.47MM | $1.46MM | $1.38MM |
| Income(Loss) | $-7.92MM | $-9.03MM | $-14.87MM |
| Taxes | $0.02MM | $0.01MM | $0.04MM |
| Profit(Loss)* | $-7.94MM | $-9.04MM | $-14.91MM |
| Stockholders Equity | $4.86MM | $2.60MM | $7.28MM |
| Inventory | $0.02MM | $0.03MM | $0.05MM |
| Assets | $8.22MM | $6.51MM | $10.96MM |
| Operating Cash Flow | $-6.04MM | $-7.26MM | $-9.33MM |
| Capital expenditure | $0.02MM | $0.08MM | $0.06MM |
| Investing Cash Flow | $-2.21MM | $-0.08MM | $-0.06MM |
| Financing Cash Flow | $-0.34MM | $5.63MM | $14.73MM |
| Earnings Per Share** | $-27.22 | $-22.36 | $-8.66 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.